Skip to main content
All lobbying filings

PERSONALIZED MEDICINE COALITION

Lobbying for PERSONALIZED MEDICINE COALITION · Health care

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $40,000.00 expenses · posted Apr 21, 2025

Official filing document

 Lobbying activity 2
Budget/Appropriations

FY 2025 Food and Drug Administration Budget Priorities for CDER, CBER and CDRH FY 2025 National Institutes of Health Budget Priorities

Health Issues

Congressional Personalized Medicine Caucus Right Drug Dose Now Act Oversight of Laboratory Developed Tests AHRQ Draft Report Blood-based Tests for Multiple Cancer Screening: A Systematic Review CMS Implementation of Medicare Drug Price Negotiation Program/ Medicare Drug Price Negotiation Program Medicare and Medicaid Programs; Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly (CMS-4208-P) Standardizing Laboratory Practices in Pharmacogenomics (STRIPE) Collaborative Community

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem